Abstract
In the Research Article “A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent,” the right panel graph of Fig. 5D (siNRP1) was erroneously duplicated in the left panel (siCtl). However, correct experimental values were reported in table S4 (provided as an Excel le) that contains raw data relating to both siCtl and siNRP1 panels of Fig. 5D. The left panel of Fig. 5D has been replaced so that it now contains a graph plotted with correct siCtl values, as originally displayed in table S4. This error does not change the ndings or conclusions of the study. The PDFs and HTML (full text) have been corrected.
| Original language | English |
|---|---|
| Article number | eaau7326 |
| Journal | Science Translational Medicine |
| Volume | 10 |
| Issue number | 451 |
| DOIs |
|
| Publication status | Published - 23 May 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Erratum for the Research Article: A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent (Science Translational Medicine DOI: 10.1126/scitranslmed.aah4807)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver